Skip to main content
EMBO Molecular Medicine logoLink to EMBO Molecular Medicine
. 2025 Apr 3;17(5):1184. doi: 10.1038/s44321-025-00228-0

Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity

Yi-Cheng Chang 1,2,3,#, Meng-Lun Hsieh 4,#, Hsiao-Lin Lee 1,2,#, Siow-Wey Hee 1, Chi-Fon Chang 5, Hsin-Yung Yen 6, Yi-An Chen 6, Yet-Ran Chen 7, Ya-Wen Chou 7, Fu-An Li 3, Yi-Yu Ke 8, Shih-Yi Chen 2, Ming-Shiu Hung 9, Alfur Fu-Hsin Hung 10, Jing-Yong Huang 1,2, Chu-Hsuan Chiu 2, Shih-Yao Lin 11, Sheue-Fang Shih 12, Chih-Neng Hsu 13, Juey-Jen Hwang 1,13, Teng-Kuang Yeh 9, Ting-Jen Rachel Cheng 5, Karen Chia-Wen Liao 14, Daniel Laio 2, Shu-Wha Lin 15,16, Tzu-Yu Chen 17, Chun-Mei Hu 5, Ulla Vogel 18, Daniel Saar 19,20,21, Birthe B Kragelund 19,20,21, Lun Kelvin Tsou 9,, Yu-Hua Tseng 22,, Lee-Ming Chuang 1,
PMCID: PMC12081718  PMID: 40181187

Correction to: EMBO Molecular Medicine. 10.1038/s44321-025-00216-4 | Published online 21 March 2025

In this article the affiliation details for Teng-Kuang Yeh were incorrectly given as “AltruBio Taiwan R&D Center, Taipei 114063, Taiwan” but should have been “Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County 35053, Taiwan”. The original article has been corrected.

In this article the e-mail address of the corresponding author Lun Kelvin Tsou was incorrect. The original article has been corrected.

Contributor Information

Lun Kelvin Tsou, Email: kelvintsou@nhri.edu.tw.

Yu-Hua Tseng, Email: yu-hua.tseng@joslin.harvard.edu.

Lee-Ming Chuang, Email: leeming@ntu.edu.tw.


Articles from EMBO Molecular Medicine are provided here courtesy of Nature Publishing Group

RESOURCES